Bond AbbVie 3.75% ( US00287YBC21 ) in USD

Issuer AbbVie
Market price 100 %  ▲ 
Country  United States
ISIN code  US00287YBC21 ( in USD )
Interest rate 3.75% per year ( payment 2 times a year)
Maturity 11/13/2023 - Bond has expired



Prospectus brochure of the bond AbbVie US00287YBC21 in USD 3.75%, expired




Minimal amount 2 000 USD
Total amount 1 250 000 000 USD
Cusip 00287YBC2
Standard & Poor's ( S&P ) rating BBB+ ( Lower medium grade - Investment-grade )
Moody's rating Baa2 ( Lower medium grade - Investment-grade )
Detailed description AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology.

AbbVie, a prominent United States-based pharmaceutical company, was the issuer of a specific fixed-income instrument, identified by ISIN US00287YBC21 and CUSIP 00287YBC2, which has since matured and been fully redeemed on November 13, 2023, at its par value of 100%. This USD-denominated bond carried an annual interest rate of 3.75% and was part of a significant issuance totaling $1,250,000,000, with a minimum purchase amount of $2,000 and interest payments occurring semi-annually. Throughout its lifecycle, the bond maintained investment-grade credit ratings of BBB+ from Standard & Poor's and Baa2 from Moody's.
DateClean price
08/07/2024100.00%
08/25/202398.96%
08/01/202398.96%
07/08/202398.96%
06/14/202398.96%
05/21/202398.96%
04/27/202398.96%
04/03/202398.96%
03/10/202398.96%
02/15/202398.96%
01/23/202398.96%
12/31/202298.96%
12/08/202298.96%
11/15/202298.96%
10/25/202297.76%
10/06/2022107.68%
09/15/2022107.68%
08/25/2022107.68%
08/04/2022107.68%
07/14/2022107.68%
06/23/2022107.68%
06/02/2022107.68%
05/12/2022107.68%
04/21/2022107.68%
03/31/2022107.68%
03/10/2022107.68%
02/17/2022107.68%
01/27/2022107.68%
01/06/2022107.68%
12/16/2021107.68%
11/25/2021107.68%
11/04/2021107.68%
10/14/2021107.68%
09/23/2021107.68%
09/02/2021107.68%
08/12/2021107.68%
07/22/2021107.68%
07/01/2021107.68%
06/10/2021107.68%
05/20/2021107.68%
04/29/2021107.68%
04/08/2021107.68%
03/21/2021107.68%
03/05/2021108.04%
02/17/2021108.55%
02/02/2021108.65%
01/21/2021108.93%
01/09/2021108.77%
12/30/2020109.06%
12/14/2020108.84%
12/01/2020109.36%
11/17/2020108.56%
11/13/2020108.87%
11/01/2020108.71%
10/24/2020108.77%
10/17/2020108.89%
10/09/2020108.80%
10/01/2020108.87%
09/23/2020109.16%
09/15/2020109.21%
09/08/2020109.18%
08/31/2020109.46%
08/24/2020109.54%
08/16/2020109.36%
08/08/2020109.59%
08/01/2020109.56%
07/24/2020109.51%
07/16/2020109.30%
07/09/2020109.14%
07/01/2020108.89%
06/23/2020108.76%
06/15/2020108.32%